Uncomplicating the Macrovascular Complications of Diabetes: The 2014 Edwin Bierman Award Lecture.

作者: Karin E. Bornfeldt

DOI: 10.2337/DB14-1963

关键词:

摘要: The risk of cardiovascular events in humans increases the presence type 1 or 2 diabetes mellitus, large part due to exacerbated atherosclerosis. Genetically engineered mouse models have begun elucidate cellular and molecular mechanisms responsible for diabetes-exacerbated Research on these has revealed that independently accelerates initiation progression lesions atherosclerosis also impairs regression following aggressive lipid lowering. Myeloid cell activation combination with proatherogenic changes allowing increased monocyte recruitment into arteries diabetic mice emerged as an important mediator effects three stages appear be dependent interplay between glucose lipids, well other factors, result monocytes both progressing regressing Importantly, some by are now being studied human subjects. This Perspective highlights new mechanistic findings based discusses relevance areas which more research is urgently needed order lessen burden macrovascular complications mellitus.

参考文章(107)
Edwin S. L. Chan, Bruce N. Cronstein, Methotrexate—how does it really work? Nature Reviews Rheumatology. ,vol. 6, pp. 175- 178 ,(2010) , 10.1038/NRRHEUM.2010.5
Andreas Holz, Thomas Dyrberg, William Hagopian, Dirk Homann, Matthias von Herrath, Michael B. A. Oldstone, Neither B Lymphocytes Nor Antibodies Directed Against Self Antigens of the Islets of Langerhans Are Required for Development of Virus-Induced Autoimmune Diabetes Journal of Immunology. ,vol. 165, pp. 5945- 5953 ,(2000) , 10.4049/JIMMUNOL.165.10.5945
Elizabeth M. Bradshaw, Khadir Raddassi, Wassim Elyaman, Tihamer Orban, Peter A. Gottlieb, Sally C. Kent, David A. Hafler, Monocytes from Patients with Type 1 Diabetes Spontaneously Secrete Proinflammatory Cytokines Inducing Th17 Cells Journal of Immunology. ,vol. 183, pp. 4432- 4439 ,(2009) , 10.4049/JIMMUNOL.0900576
Paul M Ridker, None, Closing the Loop on Inflammation and Atherothrombosis: Why Perform the Cirt and Cantos Trials? Transactions of the American Clinical and Climatological Association. ,vol. 124, pp. 174- 190 ,(2013)
Diabetes Control and Complications Trial, None, Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. The New England Journal of Medicine. ,vol. 353, pp. 2643- 2653 ,(2005) , 10.1056/NEJMOA052187
Kevin Jon Williams, Ira Tabas, The Response-to-Retention Hypothesis of Early Atherogenesis Arteriosclerosis, Thrombosis, and Vascular Biology. ,vol. 15, pp. 551- 561 ,(1995) , 10.1161/01.ATV.15.5.551
Prabhakara R. Nagareddy, Andrew J. Murphy, Roslynn A. Stirzaker, Yunying Hu, Shiquing Yu, Rachel G. Miller, Bhama Ramkhelawon, Emilie Distel, Marit Westerterp, Li-Shin Huang, Ann Marie Schmidt, Trevor J. Orchard, Edward A. Fisher, Alan R. Tall, Ira J. Goldberg, Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metabolism. ,vol. 17, pp. 695- 708 ,(2013) , 10.1016/J.CMET.2013.04.001
Renu Virmani, Allen P. Burke, Frank Kolodgie, Morphological characteristics of coronary atherosclerosis in diabetes mellitus. Canadian Journal of Cardiology. ,vol. 22, ,(2006) , 10.1016/S0828-282X(06)70991-6
Katya B. Rubinow, Valerie Z. Wall, Joel Nelson, Daniel Mar, Karol Bomsztyk, Bardia Askari, Marvin A. Lai, Kelly D. Smith, Myoung Sook Han, Anuradha Vivekanandan-Giri, Subramaniam Pennathur, Carolyn J. Albert, David A. Ford, Roger J. Davis, Karin E. Bornfeldt, Acyl-CoA Synthetase 1 Is Induced by Gram-negative Bacteria and Lipopolysaccharide and Is Required for Phospholipid Turnover in Stimulated Macrophages Journal of Biological Chemistry. ,vol. 288, pp. 9957- 9970 ,(2013) , 10.1074/JBC.M113.458372